BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32492707)

  • 1. TRIM24 promotes stemness and invasiveness of glioblastoma cells via activating Sox2 expression.
    Zhang LH; Yin YH; Chen HZ; Feng SY; Liu JL; Chen L; Fu WL; Sun GC; Yu XG; Xu DG
    Neuro Oncol; 2020 Dec; 22(12):1797-1808. PubMed ID: 32492707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological targeting of Tripartite Motif Containing 24 for the treatment of glioblastoma.
    Han M; Sun Y
    J Transl Med; 2021 Dec; 19(1):505. PubMed ID: 34886858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
    Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
    Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
    Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C
    Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma.
    Soroceanu L; Matlaf L; Khan S; Akhavan A; Singer E; Bezrookove V; Decker S; Ghanny S; Hadaczek P; Bengtsson H; Ohlfest J; Luciani-Torres MG; Harkins L; Perry A; Guo H; Soteropoulos P; Cobbs CS
    Cancer Res; 2015 Aug; 75(15):3065-76. PubMed ID: 26239477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3.
    Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ
    Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircABCC3 knockdown inhibits glioblastoma cell malignancy by regulating miR-770-5p/SOX2 axis through PI3K/AKT signaling pathway.
    Zhang H; Xu W
    Brain Res; 2021 Aug; 1764():147465. PubMed ID: 33811842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties.
    Miao H; Gale NW; Guo H; Qian J; Petty A; Kaspar J; Murphy AJ; Valenzuela DM; Yancopoulos G; Hambardzumyan D; Lathia JD; Rich JN; Lee J; Wang B
    Oncogene; 2015 Jan; 34(5):558-67. PubMed ID: 24488013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting DNA-PK induces glioma stem cell differentiation and sensitizes glioblastoma to radiation in mice.
    Fang X; Huang Z; Zhai K; Huang Q; Tao W; Kim L; Wu Q; Almasan A; Yu JS; Li X; Stark GR; Rich JN; Bao S
    Sci Transl Med; 2021 Jun; 13(600):. PubMed ID: 34193614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
    Lee Y; Kim KH; Kim DG; Cho HJ; Kim Y; Rheey J; Shin K; Seo YJ; Choi YS; Lee JI; Lee J; Joo KM; Nam DH
    PLoS One; 2015; 10(10):e0137703. PubMed ID: 26444992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation.
    Berezovsky AD; Poisson LM; Cherba D; Webb CP; Transou AD; Lemke NW; Hong X; Hasselbach LA; Irtenkauf SM; Mikkelsen T; deCarvalho AC
    Neoplasia; 2014 Mar; 16(3):193-206, 206.e19-25. PubMed ID: 24726753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma.
    Lv D; Li Y; Zhang W; Alvarez AA; Song L; Tang J; Gao WQ; Hu B; Cheng SY; Feng H
    Nat Commun; 2017 Nov; 8(1):1454. PubMed ID: 29129908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells.
    Lopez-Bertoni H; Lal B; Michelson N; Guerrero-Cázares H; Quiñones-Hinojosa A; Li Y; Laterra J
    Oncogene; 2016 Sep; 35(37):4903-13. PubMed ID: 26898758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANO1 regulates the maintenance of stemness in glioblastoma stem cells by stabilizing EGFRvIII.
    Kim HJ; Kim JY; Jung CW; Lee YS; An JY; Kim EH; Kim KH; Lee SP; Park JY; Park MJ
    Oncogene; 2021 Feb; 40(8):1490-1502. PubMed ID: 33452454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ER stress and UPR activation in glioblastoma: identification of a noncanonical PERK mechanism regulating GBM stem cells through SOX2 modulation.
    Peñaranda-Fajardo NM; Meijer C; Liang Y; Dijkstra BM; Aguirre-Gamboa R; den Dunnen WFA; Kruyt FAE
    Cell Death Dis; 2019 Sep; 10(10):690. PubMed ID: 31534165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
    Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K
    Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential role of METTL3-mediated m
    Visvanathan A; Patil V; Arora A; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
    Oncogene; 2018 Jan; 37(4):522-533. PubMed ID: 28991227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.
    Binder ZA; Siu IM; Eberhart CG; Ap Rhys C; Bai RY; Staedtke V; Zhang H; Smoll NR; Piantadosi S; Piccirillo SG; Dimeco F; Weingart JD; Vescovi A; Olivi A; Riggins GJ; Gallia GL
    PLoS One; 2013; 8(10):e75945. PubMed ID: 24146797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
    Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.